Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04NQZ
|
|||
| Former ID |
DNCL003295
|
|||
| Drug Name |
V502
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human papillomavirus infection [ICD-11: 1A9Y; ICD-9: 078.1079.4] | Phase 1 | [1] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00851643) Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.